Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Elena Biagioli"'
Autor:
Janus Christian Jakobsen, Christian Gluud, Lehana Thabane, Lawrence Mbuagbaw, Ole Mathiesen, Eliana Rulli, Elena Biagioli, Caroline Kamp Jørgensen, Mathias Lühr Hansen, Maria Chiaruttini
Publikováno v:
BMJ Open, Vol 13, Iss 6 (2023)
Introduction It is essential to choose a realistic anticipated intervention effect when calculating a sample size for a randomised clinical trial. Unfortunately, anticipated intervention effects are often inflated, when compared with the ‘true’ i
Externí odkaz:
https://doaj.org/article/4145ffa04d1f43cd8a9a7ea3166d4cd8
Autor:
Caroline Kamp Jørgensen, Markus Harboe Olsen, Niklas Nielsen, Theis Lange, Lawrence Mbuagbaw, Lehana Thabane, Laurent Billot, Nadine Binder, Silvio Garattini, Rita Banzi, Jacques Demotes, Elena Biagioli, Eliana Rulli, Guido Bertolini, Giovanni Nattino, Ole Mathiesen, Valter Torri, Christian Gluud, Janus Christian Jakobsen
Publikováno v:
Health Services Insights, Vol 16 (2023)
When conducting randomised clinical trials, the choice of methodology and statistical analyses will influence the results. If the planned methodology is not of optimal quality and predefined in detail, there is a risk of biased trial results and inte
Externí odkaz:
https://doaj.org/article/057f639a9e49438bb30bebf4cc7d75f0
Autor:
Anaid Anna Kasangian, Giorgio Gherardi, Elena Biagioli, Valter Torri, Anna Moretti, Elena Bernardin, Andrea Cordovana, Gabriella Farina, Annalisa Bramati, Sheila Piva, Maria Chiara Dazzani, Emanuela Paternò, Nicla Maria La Verde
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0189127 (2017)
The prognosis of early breast cancer (EBC) depends on patient and tumor characteristics. The association between tumor size, the largest diameter in TNM staging, and prognosis is well recognized. According to TNM, tumors classified as T2, could have
Externí odkaz:
https://doaj.org/article/de6c3049fb174f01b8b85f088a62cf5b
Autor:
Maurizio Polano, Luca Bedon, Michele Dal Bo, Roberto Sorio, Michele Bartoletti, Elena De Mattia, Erika Cecchin, Carmela Pisano, Domenica Lorusso, Andrea Alberto Lissoni, Andrea De Censi, Sabrina Chiara Cecere, Paolo Scollo, Sergio Marchini, Laura Arenare, Ugo De Giorgi, Daniela Califano, Elena Biagioli, Paolo Chiodini, Francesco Perrone, Sandro Pignata, Giuseppe Toffoli
Publikováno v:
Clinical Pharmacology & Therapeutics.
Autor:
Nicoletta Colombo, Federica Tomao, Pierluigi Benedetti Panici, Maria Ornella Nicoletto, Germana Tognon, Alessandra Bologna, Andrea Alberto Lissoni, Andrea DeCensi, Mariateresa Lapresa, Rosanna Mancari, Innocenza Palaia, Giulia Tasca, Francesca Tettamanzi, Maria Francesca Alvisi, Eliana Rulli, Davide Poli, Luciano Carlucci, Valter Torri, Roldano Fossati, Elena Biagioli
Background: Previous findings showed that cediranib-olaparib increased PFS in women with recurrent platinum-sensitive ovarian cancer compared to olaparib alone. Methods: BAROCCO trial randomized 123 patients: 80 mg/m2 paclitaxel weekly up to 24 weeks
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a50894eb2b17531be40c0f3ed8a7a185
http://hdl.handle.net/11573/1643684
http://hdl.handle.net/11573/1643684
Autor:
Robert N. Weinreb, Elena Biagioli, Eliana Rulli, Francesco Oddone, Manuele Michelessi, Ivano Riva, Luciano Quaranta, Maurizio G. Uva, Francesca Galli, Antonio Longo
Publikováno v:
Journal of Glaucoma. 29:441-447
Precis Central corneal thickness (CCT) may increase over time in children affected by primary congenital glaucoma and treated with latanoprost for at least 30 months. Purpose The purpose of this study was to investigate CCT modification over time in
Autor:
Maurizio D'Incalci, Elena Biagioli, Eliana Rulli, Luca Porcu, Rino Bellocco, Francesca Ghilotti, Mirko Marabese, Valter Torri
Publikováno v:
British Journal of Cancer
Background: The evaluation of the proportional hazards (PH) assumption in survival analysis is an important issue when Hazard Ratio (HR) is chosen as summary measure. The aim is to assess the appropriateness of statistical methods based on the PH ass
Autor:
Nicoletta Colombo, Elena Biagioli, Lara Paracchini, Maurizio D'Incalci, Tommaso Grassi, Fabio Landoni, Lorenzo Ceppi, Sergio Marchini, Robert Fruscio, Annalisa Garbi, P Di Lorenzo, Giovanni Aletti, Sharon Palazzi, Chiara Romualdi
Publikováno v:
ePoster.
Introduction/Background The activation of TGFβ pathway in advanced stage high-grade serous ovarian cancer (HGSOC) has been found to be related to short progression free survival (PFS) and overall survival (OS). miRNA181a-5p was found to be a proxy o
Publikováno v:
Cancer. 123:3450-3459
The platinum-free interval is the most important predictive factor of a response to subsequent lines of chemotherapy and the most important prognostic factor for progression-free and overall survival in patients with recurrent epithelial ovarian canc
Autor:
Carolina Maria Sassu, Erlisa Bardhi, Anna Di Pinto, Maria Cristina Petrella, Elena Biagioli, Pierluigi Benedetti Panici, Innocenza Palaia, Ludovico Muzii, Nicoletta Colombo, Federica Tomao
Publikováno v:
Cancer treatment reviews. 80
Objective: This meta-analysis investigated the effectiveness of PARP inhibitors (PARPis) as maintenance treatment in platinum sensitive recurrent ovarian cancer (ROC), stratifying results based on BRCA mutational status into five different categories